Suchergebnisse - "Zaldívar-Díez, Josefa"

PubPharm (13)

1

Cognitive enhancement, TAU phosphorylation reduction, and neuronal protection by the treatment of an LRRK2 inhibitor in a tauopathy mouse model

enthalten in: Neurobiology of aging | 2020

von Castro-Sánchez, S. | Zaldivar-Diez, J. | Luengo, E. | +4

2

Benzothiazole-Based LRRK2 Inhibitors as Wnt Enhancers and Promoters of Oligodendrocytic Fate

enthalten in: Journal of medicinal chemistry | 2020

von Zaldivar-Diez, J. | Li, L. | Garcia, A. | +6

3

Discovery of novel Schistosoma mansoni PDE4A inhibitors as potential agents against schistosomiasis

enthalten in: Future medicinal chemistry | 2019

von Sebastián-Pérez, V. | Schroeder, S. | Munday, J. | +9

4

Discovery of novelSchistosoma mansoniPDE4A inhibitors as potential agents against schistosomiasis

enthalten in: Future medicinal chemistry | 2019

von Sebastián-Pérez, V. | Schroeder, S. | Munday, J. | +9

5

Tau-Centric Multitarget Approach for Alzheimer's Disease : Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors

enthalten in: Journal of medicinal chemistry | 2018

von Gandini, A. | Bartolini, M. | Tedesco, D. | +16

6

Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa

enthalten in: Molecular neurodegeneration | 2018

von Sánchez-Cruz, A. | Villarejo-Zori, B. | Marchena, M. | +8

7

Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa

enthalten in: Molecular neurodegeneration | 2018

von Sánchez-Cruz, A. | Villarejo-Zori, B. | Marchena, M. | +8

8

LRRK2 inhibitors as effective drugs for the treatment of neurodegenerative diseases

Erschienen: Dissertation, CSIC - Centro de Investigaciones Biológicas (CIB); Universidad CEU San Pablo, 2018

von Zaldívar-Díez, J.

9

Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2017

von Marchena, M. | Villarejo-Zori, B. | Zaldivar-Diez, J. | +5

10

Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold : Potential pro-neurogenic agents

enthalten in: European journal of medicinal chemistry | 2017

von Salado, I. | Zaldivar-Diez, J. | Sebastián-Pérez, V. | +8